Overview A Study to Evaluate CBP-201 in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps Status: Recruiting Trial end date: 2023-01-01 Target enrollment: Participant gender: Summary This study will evaluate the effect of CBP-201 in adult patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Phase: Phase 2 Details Lead Sponsor: Suzhou Connect Biopharmaceuticals, Ltd.